- Home
- IMNM vs WTFCM Comparison
IMNM vs WTFCM Comparison
Compare IMNM & WTFCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- WTFCM
- Stock Information
- Founded
- IMNM 2006
- WTFCM N/A
- Country
- IMNM United States
- WTFCM United States
- Employees
- IMNM N/A
- WTFCM 5903
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- WTFCM Major Banks
- Sector
- IMNM Health Care
- WTFCM Finance
- Exchange
- IMNM Nasdaq
- WTFCM Nasdaq
- Market Cap
- IMNM 748.3M
- WTFCM N/A
- IPO Year
- IMNM 2020
- WTFCM N/A
- Fundamental
- Price
- IMNM $8.77
- WTFCM $25.00
- Analyst Decision
- IMNM Strong Buy
- WTFCM
- Analyst Count
- IMNM 5
- WTFCM 0
- Target Price
- IMNM $26.40
- WTFCM N/A
- AVG Volume (30 Days)
- IMNM 1.1M
- WTFCM N/A
- Earning Date
- IMNM 08-11-2025
- WTFCM N/A
- Dividend Yield
- IMNM N/A
- WTFCM N/A
- EPS Growth
- IMNM N/A
- WTFCM N/A
- EPS
- IMNM N/A
- WTFCM N/A
- Revenue
- IMNM $10,938,000.00
- WTFCM N/A
- Revenue This Year
- IMNM N/A
- WTFCM N/A
- Revenue Next Year
- IMNM $310.65
- WTFCM N/A
- P/E Ratio
- IMNM N/A
- WTFCM N/A
- Revenue Growth
- IMNM N/A
- WTFCM N/A
- 52 Week Low
- IMNM $5.15
- WTFCM N/A
- 52 Week High
- IMNM $16.81
- WTFCM N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 49.38
- WTFCM 33.17
- Support Level
- IMNM $8.60
- WTFCM $24.94
- Resistance Level
- IMNM $9.27
- WTFCM $24.99
- Average True Range (ATR)
- IMNM 0.46
- WTFCM 0.01
- MACD
- IMNM -0.03
- WTFCM -0.03
- Stochastic Oscillator
- IMNM 44.57
- WTFCM 13.10
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About WTFCM Wintrust Financial Corporation Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series D
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.